Collana IT has acquired all the shares in the Swiss Neolution, a company specialized in complex web and mobile solutions with outstanding testimonials from financial institutions, insurances and companies in the field of telecommunication,
Tags :Walder Wyss
Walder Wyss and Heussen law firm, Munich, represented client Terra Quantum, a Swiss based quantum technology company, in an extension of its series A financing round in a total amount of USD 75 million.
Usr Unité de Secours Régional, a company in the field of rescue, medical transfers and the provision of paramedical services in the canton of Vaud. As of 28 March 2022, became part of TCS Swiss Ambulance
Swiss FinTech startup Teylor has successfully closed its CHF 6.5 million series A2 financing round. The additional funds will be used to strengthen the market position of the Teylor lending platform, a platform providing banks, debt
Yokoy Group has completed its series B financing round raising USD 80 million in, led by US investor Sequoia Capital with participation from Speedinvest, Visionaries Club and Zinal Growth, existing investors Balderton Capital, Six FinTech Ventures,
Walder Wyss partner Fabienne Limacher (pictured) has been elected as a member of the bank council of the cantonal bank of the Canton of Nidwalden by the Council of State of the Canton of Nidwalden
The two former shareholders, Shayesteh Fürst-Ladani und Walter Fürst, have sold 100% of the shares in all SFL group companies with their registered seats in Switzerland (SFL Regulatory Affairs & Scientific Communication und SFL
The Otto Group, an international trading and service company, has acquired a majority stake in Medgate Holding. Otto Group became the new majority shareholder of Medgate Holding by subscribing to all the new shares created
Bank J. Safra Sarasin acquires the remaining 42.5% of the Swiss online bank zweiplus from Aabar Trading, a subsidiary of the sovereign wealth fund of Abu Dhabi. bank zweiplus will remain a FINMA-licensed company and operate
Memo Therapeutics, specialists in the field of antibody discovery and development, has closed an oversubscribed Series B financing round led by Swisscanto Invest at CHF37 million after securing an additional CHF23 million from a combination
